Real-world benefits and tolerability of trofinetide for the treatment of Rett syndrome: The LOTUS study | Louise Cosand | DMCN
Audio is streamed directly from the publisher (mcdn.podbean.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this podcast, Louise Cosand discusses her paper 'Real-world benefits and tolerability of trofinetide for the treatment of Rett syndrome: The LOTUS study'.
The paper is available here: https://doi.org/10.1111/dmcn.16482
Follow DMCN on Podbean for more: https://dmcn.podbean.com/
___
Watch DMCN Podcasts on YouTube:
__
DMCN Journal:
Developmental Medicine & Child Neurology (DMCN) has defined the field of paediatric neurology and childhood-onset neurodisability for over 60 years. DMCN disseminates the latest clinical research results globally to enhance the care and improve the lives of disabled children and their families.
DMCN Journal - https://onlinelibrary.wiley.com/journal/14698749
___
Find us on Twitter!
@mackeithpress - https://twitter.com/mackeithpress